✦ LIBER ✦

Breast conservation therapy: 417 breast cancers with a minimum follow-up period of five years

✍ Scribed by R. Kuske; P. Compaan; M. Cross; D. Garcia; D. Stahl; B. Aron; M. Popp; G. Philpott; C. Perez; B. Fineberg

Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 251 KB
Volume: 17
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(89)90857-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast conservation in the treatment of

Breast conservation in the treatment of early breast cancer a 20-year follow-up

✍ Michael P. Osborne; Nigel Ormiston; Clive L. Harmer; J. Alan Mckinna; Joan Baker 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

Prognostic factors of breast recurrence

Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up

✍ Alain Fourquet; François Campana; Brigitte Zafrani; Véronique Mosseri; Philippe 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 829 KB

Levamisole in the treatment of stage II

Levamisole in the treatment of stage II breast cancer five-year follow-up of a randomized double-blind study

✍ Pentti Klefström; Paul Holsti; Pentti Gröhn; Erkki Heinonen; Lars Holsti 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 3 views

Twenty-five years of follow-up in patien

Twenty-five years of follow-up in patients with operable breast carcinoma : Correlation between clinicopathologic factors and the risk of death in each 5-year period

✍ Rodrigo Arriagada; Monique G. Le; Ariane Dunant; Maurice Tubiana; Genevieve Cont 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Late follow-up of a randomized trial of

Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer

✍ M. Fennessy; T. Bates; K. MacRae; D. Riley; J. Houghton; M. Baum 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background Breast cancer has been considered a more indolent disease in the elderly, who are less tolerant of aggressive therapy. This trial tested the hypothesis that tamoxifen without surgery would provide adequate control of breast cancer for the remainder of life in elderly wome